ProShare Advisors
ATOS icon

ProShare Advisors’s Atossa Therapeutics ATOS Stock Holding History

ProShare Advisors’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,825
Closed -$18.4K – 2084
2025
Q1 		$18.4K Sell
1,825
-550
-23% -$6.68K ﹤0.01% 2044
2024
Q4 		$33.6K Buy
2,375
+782
+49% +$15.3K ﹤0.01% 2229
2024
Q3 		$36.3K Buy
+1,593
New +$32.2K ﹤0.01% 2011
2022
Q2 		– Sell
-1,462
Closed -$28K – 1818
2022
Q1 		$28K Sell
1,462
-242
-14% -$4.92K ﹤0.01% 2158
2021
Q4 		$41K Buy
1,704
+704
+70% +$25.8K ﹤0.01% 2302
2021
Q3 		$49K Sell
1,000
-1,023
-51% -$59.5K ﹤0.01% 1965
2021
Q2 		$192K Buy
+2,023
New +$107K ﹤0.01% 2156

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return